v, The cerebrospinal fluid (CSF) and plasma levels of the complement components C3a and C4a in 40 patients suffering from subarachnoid hemorrhage (SAH) were quantitated by radioimmunoassay. Serial measurements of the lumbar CSF levels revealed that the C3a and C4a levels were significantly elevated in the initial stage of SAH, but decreased rapidly. Within 48 hours after SAH, the mean C3a and C4a levels in the cisternal, lumbar, and ventricular CSF were significantly higher in patients with delayed ischemic neurological deficits (DIND) than in those without DIND. The serially measured plasma levels of C3a and C4a in patients with DIND were elevated more than in those without DIND, but they did not show a significant change over time. Simultaneous levels of fibrinopeptide A (FPA), an indicator of thrombin activity in CSF, were also measured by radioimmunoassay. There was a significant correlation between CSF-activated complement components and CSF FPA. These results suggest that complement activation occurred in the subarachnoid space soon after SAH, chiefly due to activation of the coagulation system. The higher CSF levels of C3a and C4a in patients with DIND may indicate a relationship between these components and the pathogenesis of cerebral vasospasms.
I
N spite of extensive clinical and experimental research, the pathogenesis of delayed cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) has not been clarified. In our previous studies, we examined the relationship between the etiology of vasospasms after SAH and the activation of the coagulation, fibrinolytic, kinin, and complement systems 9"~ on the basis that vasospasm is linked to an inflammatory response in the subarachnoid space after SAH.2.14 There has been no report of studies examining the activated complement components in patients with SAH. In the present study, the levels of C3a and C4a in cerebrospinal fluid (CSF) and plasma were monitored in a series of patients with SAH. The relationship between complement activation and the activation of the coagulation system was also examined by measuring fibrinopeptide A (FPA).
Clinical Material and Methods

Patient Population
The series included 40 patients (23 women and 17 men) who ranged in age from 34 to 84 years (mean age 55.2 years). The clinical data are summarized in Table   1 . The patients' clinical status was graded according to the classification of Hunt and Hess. 12 The amount of blood in the subarachnoid space was estimated from computerized tomography (CT) scans according to the criteria of Fisher, et al. 4 The presence of cerebral vasospasms was identified by the occurrence of delayed ischemic neurological deficits (DIND) or cerebral infarction, and by angiography. The development of DIND could not be determined in four patients because of primary cerebral damage or aneurysmal rebleeding. Control samples of lumbar CSF were obtained during myelography from patients with intravertebral pathology. For ethical reasons, control samples of cisternal and ventricular CSF were not available. Control plasma samples were collected from healthy volunteers.
Sampling Procedure
The lumbar CSF samples and blood samples were collected serially for 15 days beginning at the onset of hemorrhage. The ventricular and cisternal CSF samples were obtained at the time of the operation or by postoperative CSF drainage. Two milliliters of CSF and blood were collected into a plastic tube containing 7.5 
* ACA = anterior communicating artery or anterior cerebral artery; ICA = internal cerebral artery; MCA = middle cerebral artery; VA = vertebral artery; DIND = delayed ischemic neurological deficits. -= factor absent; + = factor present; ++ = factor severe. Numbers in parentheses indicate day after SAH (Day 0 = day of SAH).
t Clinical grading according "to the classification of Hunt and Hess. ~2
:~ Degree of SAH as defined on computerized tomography by Fisher, et al. 4
w Outcome: excellent = no neurological deficits; good = focal neurological deficit without limitation of activity; partial disability; poor = total disability; or death.
11 Cases with collection of blood samples.
mg of ethylenediaminetetra-acetic acid disodium salt and 150 mg of nafamostat mesilate. After centrifugation at 1500 G for 5 minutes at 4"C, the supernatant fluid was collected and stored at -20~ until assayed.
Radioimmunoassay of C3a, C4a, and FPA
The C3a and C4a components were quantitatively measured by radioimmunoassay.* The C3a component * Radioimmunoassay kits obtained from Amersham, Inc., London, England.
was assayed according to a method developed by Hugli and Chenoweth, 1~ and the radioimmunoassay technique for C4a was that described by Gorski. 6 Fibrinopeptide A levels in the CSF at the time of sampling for activated complement components were determined by radioimmunoassay as previously reported.13
Statistical Analysis
The results were statistically evaluated using Student's t-test for unpaired differences after logarithmic 
Cerebrospinal Fluid Components
No. Collection (hrs) (ng/ml) (ng/ml) (ng/ml) Figure 1 shows the l u m b a r CSF C3a . There were significant positive correlations between CSF levels of activated c o m p l e m e n t components and the FPA in the CSF (Fig. 3 ).
* Levels of C3a, C4a, and fibrinopeptide A (FPA) within 48 hours (median 17.2 hours) after subarachnoid hemorrhage. DIND = delayed ischemic neurological deficits. Figure 4 shows the plasma C3a and C4a levels in 32 samples obtained over 15 days after SAH from 16 patients. These values did not show significant change H. Kasuya and T. Shimizu over time. The C3a levels of the SAH patients with DIND were always higher than control values. The C4a levels of the SAH patients with DIND were higher than control values between Days 3 and 10. The C3a and C4a levels in the SAH patients without DIND showed no significant difference compared with control values.
P l a s m a Components
Discussion
The possible interactions between proteins of the complement, coagulation, kinin, and fibrinolytic systems are numerous, but few have been investigated in any detail. It is well recognized that thrombin, kallikrein, and plasmin can cleave complement proteins. 16 Recently, the biological significance of the interaction between the complement system and the activated Hageman factor has been the subject of considerable interest. Activation of the Hageman factor leads to a cascade of the coagulation system (intrinsic system). The Hageman factor of major control proteins activates plasma prekallikrein to form kallikrein, which in turn cleaves high-molecular-weight kininogen to produce bradykinin. A fragment of the activated Hageman factor has been demonstrated to activate the classical complement pathway 5 (Fig. 5) .
In the previous study, we measured FPA and showed that the coagulation system in CSF is strongly activated in the early stage of SAH. We also showed that SAH formed bradykinin in the subarachnoid space in the initial stage, which is possibly due to the contact activation of the Hageman factor.13 This study has shown that the CSF of patients with aneurysmal SAH contains an increased concentration of C3a and C4a in the initial stage of SAH. The CSF levels of C3a and C4a were much higher than those of the plasma. This phenomenon suggests that the CSF C3a and C4a might be formed in the subarachnoid space and that these anaphylatoxins might be present in a much higher concentration at the bleeding point. The generation of these complement cleavage products signals the activation of the complement cascade. The elevated levels of not only C3a but also C4a only involve the classical pathway. It was suggested that the classical pathway was mainly activated in the subarachnoid space after SAH. There was a significant correlation between CSF-activated complement components and CSF FPA as an indicator of thrombin activity. The formation of C3a and C4a in the subarachnoid space after SAH might chiefly be due to activation of the coagulation system. The contact stimulation of the Hageman factor was considered to have a possible role in activating a large part of the complement system as well as the coagulation and kinin systems. These related systems that activated the alternative pathway were involved in increasing the levels of C3a because CSF levels of C3a were much higher and more correlated than those of C4a.
During the initial stage of SAH, cerebral vasospasm was not seen; however, Chyatte, et al., ~ reported that steroid treatment was effective only when it was started soon after SAH. Handa, et al., 7 indicated that surgical clot removal in the early stages is likely to be useful only when the operation is performed within 48 hours of SAH. It is suggested that the early stages of SAH might be important for the pathogenesis of cerebral vasospasm. At this time, patients with delayed cerebral vasospasm have high levels of the activated complement components C3a and C4a compared to patients without vasospasm.
The major involvement of anaphylatoxins (C3a, C4a, and C5a) in pathological conditions most likely lies in their participation in the acute inflammatory response. They play significant roles as mediators in acute inflammation. Anaphylatoxins produce immediate vasoconstriction and enhancement of vascular permeability within the microcirculatory system, cause localized degranulation of mast cells, and excite chemotaxis of leukocytes through a barrier such as the vascular endothelium, t t D6czi 3 stressed the importance of the disturbed blood-brain barrier in the pathophysiology of SAH at the acute stage, especially in patients with an unfavorable clinical course) Complement activation might be responsible for vasospasm by causing disruption of the blood-brain barrier or other inflammatory reactions.
~stergaard, et aL, ~4 showed a twofold increase in plasma C3d levels at the time when the spasm occurred, but no significant changes were seen in patients without vasospasm. The activation of the plasma complement system was considered to be caused by the presence of circulating immune complexes. The serially measured plasma levels of C3a and C4a in patients with DIND were elevated more than in those without DIND, but they did not show a statistically significant change over time. From this study, it was difficult to appreciate the relationship between the complement activation in plasma and vasospasm. The levels of C3a and C4a in circulating blood could be influenced by many factors of the systemic condition. The high levels of C3a and C4a from the day of the hemorrhage might be due to systemic disease caused by the SAH itself. In fact, the patients with DIND were generally in worse neurological condition on admission than were those without DIND (Table 1) . No conclusion could be reached from this study about a direct correlation between C3a and C4a levels in plasma and vasospasm.
